Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening

NCT05180305 is registered in ClinicalTrials.gov with TSH Biopharm Corporation Limited as lead sponsor.

NCT NCT05180305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05180305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening
Lead sponsor
TSH Biopharm Corporation Limited
Phase
Observational
Overall status
Unknown status
Start date
April 27, 2021
Completion date
December 31, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer